Optimization of linear and cyclic peptide inhibitors of KEAP1-NRF2 protein-protein interaction
Stefania Colarusso(IRBM Science Park), Elisabetta Bianchi(IRBM Science Park), Antonino Missineo(IRBM Science Park), Larry Park(CHDI Foundation), Ignacio Muñoz-Sanjuán(CHDI Foundation), Daniele Moretti(University of Siena), Vincenzo Summa(IRBM Science Park), Stefan Steinbacher, Georg Kempf, Mauro Cerretani(IRBM Science Park), Leticia Toledo‐Sherman(CHDI Foundation), Celia Dominguez(CHDI Foundation), Licia Tomei(IRBM Science Park), Alberto Bresciani(University of Bergamo), Matteo Andreini(Siena Biotech (Italy)), Martin Augustin, Daniele De Simone, Sara Tambone(IRBM Science Park), Tommaso Frattarelli(IRBM Science Park)
Cited by 27
Related Papers
The promise and peril of chemical probes
|Nature Chemical Biology|2015|848
A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope
|Proceedings of the National Academy of Sciences|2005|156
Design, Synthesis, and Biological Evaluation of Potent and Selective Class IIa Histone Deacetylase (HDAC) Inhibitors as a Potential Therapy for Huntington’s Disease
|Journal of Medicinal Chemistry|2013|149
Adipogenesis of skeletal muscle fibro/adipogenic progenitors is affected by the WNT5a/GSK3/β-catenin axis
|Cell Death and Differentiation|2020|149